SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001683168-21-003825
Filing Date
2021-08-20
Accepted
2021-08-20 20:35:44
Documents
1
Period of Report
2021-08-10

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 9950
  Complete submission text file 0001683168-21-003825.txt   11541
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Issuer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PHARMACYTE BIOTECH INC. 23046 AVENIDA DE LE CORLOTA LAGUNA HILLS CA 10041-0099
Business Address
Abecassis Michael M (Reporting) CIK: 0001879281 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40699 | Film No.: 211195082